ArticleCancers2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.
Stefano Molica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancers2026
Stefano Molica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.